Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview

CASI Pharmaceuticals

12/08/2025 14:21

CASI Pharmaceuticals Inc CASI.OQ CASI.O is expected to  show a rise in quarterly revenue when it reports  results on August 14 (estimated) for the period ending June 30 2025

The Beijing-based  company is expected to report a 58.3% increase in revenue to $6.3 million from $3.98 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for CASI Pharmaceuticals Inc is for a loss of 47 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for CASI Pharmaceuticals Inc is $4.00, about 56.8% above its last closing price of $1.73

This summary was machine generated August 12 at 13:21 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)